268 related articles for article (PubMed ID: 19266083)
21. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
22. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
23. Identification of Viral and Host Proteins That Interact with Murine Gammaherpesvirus 68 Latency-Associated Nuclear Antigen during Lytic Replication: a Role for Hsc70 in Viral Replication.
Salinas E; Byrum SD; Moreland LE; Mackintosh SG; Tackett AJ; Forrest JC
J Virol; 2016 Feb; 90(3):1397-413. PubMed ID: 26581985
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation.
Nakajima K-i; Inagaki T; Espera JM; Izumiya Y
J Virol; 2024 Feb; 98(2):e0126823. PubMed ID: 38240588
[TBL] [Abstract][Full Text] [Related]
25. KSHV LANA--the master regulator of KSHV latency.
Uppal T; Banerjee S; Sun Z; Verma SC; Robertson ES
Viruses; 2014 Dec; 6(12):4961-98. PubMed ID: 25514370
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
Paudel N; Sadagopan S; Balasubramanian S; Chandran B
J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
[TBL] [Abstract][Full Text] [Related]
27. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores.
Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES
J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191
[TBL] [Abstract][Full Text] [Related]
28. H2AX phosphorylation is important for LANA-mediated Kaposi's sarcoma-associated herpesvirus episome persistence.
Jha HC; Upadhyay SK; A J Prasad M; Lu J; Cai Q; Saha A; Robertson ES
J Virol; 2013 May; 87(9):5255-69. PubMed ID: 23449797
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
[TBL] [Abstract][Full Text] [Related]
30. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences.
Watanabe A; Higuchi M; Fukushi M; Ohsawa T; Takahashi M; Oie M; Fujii M
Virus Genes; 2007 Apr; 34(2):127-36. PubMed ID: 17143723
[TBL] [Abstract][Full Text] [Related]
31. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection.
Li S; Wang M; Van Sciver N; Szymula A; Tumuluri VS; George A; Ramachandran A; Raina K; Costa CN; Zhao B; Kazemian M; Simas JP; Kaye KM
PLoS Pathog; 2024 Jan; 20(1):e1011907. PubMed ID: 38232124
[TBL] [Abstract][Full Text] [Related]
33. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs.
Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501
[TBL] [Abstract][Full Text] [Related]
34. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.
Lu F; Day L; Gao SJ; Lieberman PM
J Virol; 2006 Jun; 80(11):5273-82. PubMed ID: 16699007
[TBL] [Abstract][Full Text] [Related]
35. Latency-associated nuclear antigen inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by regulating let-7a/RBPJ signaling.
Qi Y; Zheng G; Di C; Zhang J; Wang X; Hong Y; Song Y; Chen R; Yang Y; Yan Y; Xu L; Tan X; Yang L
Virology; 2019 May; 531():69-78. PubMed ID: 30856484
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
[TBL] [Abstract][Full Text] [Related]
37. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
[TBL] [Abstract][Full Text] [Related]
38. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
[TBL] [Abstract][Full Text] [Related]
39. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
40. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
